Willard ("Bill") E. Fee, Jr.
Academic Appointments
- Emeritus Faculty, Acad Council, Otolaryngology (Head and Neck Surgery)
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Otolaryngology - Head/Neck Surgery 875 Blake Wilbur Dr Clinic B Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 725-8502
- Academic Offices
Personal Information Tel (650) 725-6500Alternate Contact cell phone Tel Work 650 787-5294Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Head and Neck Cancer
- Otolaryngology
- Head and Neck Tumor Surgery
- Nasopharyngeal Cancer
Honors and Awards
- Member, UGC Hong Kong Task Force on Vet School (2012-present)
- Member, University Grants Committee, Hong Kong (2007-2012)
Professional Education
| Board Certification: | Otolaryngology, American Board of Otolaryngology (1974) |
| Residency: | UCLA Medical Center CA (1974) |
| Residency: | Wadsworth General Hospital - VA CA (1971) |
| Internship: | Harbor-UCLA Medical Center CA (1970) |
| Medical Education: | University of Colorado School of Medicine CO (1969) |
Graduate & Fellowship Program Affiliations
Community and International Work
- University Grants Committee, Hong Kong, China&suffix=
Scientific Focus
Current Research Interests
Clinical Trials
- Recruiting Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
- Not Recruiting Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
- Not Recruiting A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
- Not Recruiting Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
Publications
- Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013; (7): 1349-56
- Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 2012 Mar-Apr; (2): 166-73
- A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012; (3): 994-9
- Nasopharyngeal carcinoma: Salvage of local recurrence Oral Oncology. 2012; (9): 768-774
- Salvage Treatment for Locally Recurrent Nasopharyngeal Carcinoma (NPC). Am J Clin Oncol. 2012
- Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer. Head Neck. 2011; (12): 1666-74
Help
Trial Administration